Renovaro Biosciences Inc. (RENB)

USD 1.68

(1.2%)

Annual Balance Sheets

(In USD)
Breakdown 2024 2023 2022 2021 2020 2019
Total Assets 163.12 Million 58.3 Million 84.63 Million 189.6 Million 178.1 Million 179.87 Million
Total Current Assets 1.99 Million 2.56 Million 9.56 Million 20.89 Million 8.94 Million 12.49 Million
Cash And Short Term Investments 220.46 Thousand 1.87 Million 9.17 Million 20.66 Million 8.69 Million 12.28 Million
Cash and Cash Equivalents 220.46 Thousand 1.87 Million 9.17 Million 20.66 Million 8.69 Million 12.28 Million
Short Term Investments - - - - - -
Net Receivables 1.1 Million - - 1640.00 1982.00 20.79 Thousand
Inventory -439.31 Thousand - - -1640.00 - -
Other Current Assets 668.92 Thousand 690.92 Thousand 392.99 Thousand 234.58 Thousand 242.86 Thousand 191.96 Thousand
Total Non-Current Assets 161.13 Million 55.73 Million 75.06 Million 168.7 Million 169.16 Million 167.38 Million
Net PPE 1.75 Million 1.42 Million 1.74 Million 2.15 Million 2.48 Million 687.51 Thousand
Good Will And Intangible Assets 159.36 Million 54.29 Million 73.25 Million 166.52 Million 166.54 Million 11.64 Million
Good Will 159.33 Million 11.64 Million 11.64 Million 11.64 Million 11.64 Million 11.64 Million
Intangible Assets 30.04 Thousand 42.65 Million 61.61 Million 154.88 Million 154.9 Million -
Long-Term Investments - - - - - -
Tax Assets - - - - - -
Other Non Current Assets 19.84 Thousand 21.74 Thousand 68.63 Thousand 20.98 Thousand 137.55 Thousand 155.05 Million
Other Assets - - - - - -
Total Liabilities 31.15 Million 11.79 Million 12.01 Million 14.94 Million 11.82 Million 6.77 Million
Total Current Liabilities 30.3 Million 11.02 Million 6.45 Million 1.88 Million 1.33 Million 1.11 Million
Account Payables 9.44 Million 5.29 Million 1.4 Million 320.55 Thousand 592.87 Thousand 773.56 Thousand
Tax Payables - - - - - -
Short Term Debt 2.45 Million 4.81 Million 1.45 Million 292.4 Thousand 271.28 Thousand -
Deferred Revenue 5.8 Million 723.17 Thousand 1.03 Million 1.18 Million - -
Other Current Liabilities 12.6 Million 184.73 Thousand 2.56 Million 90.6 Thousand 470.63 Thousand 336.85 Thousand
Total Non Current Liabilities 842.38 Thousand 775.58 Thousand 5.56 Million 13.05 Million 10.49 Million 5.66 Million
Long-Term Debt 842.38 Thousand 775.58 Thousand 5.56 Million 7.01 Million 7.31 Million -
Deferred Revenue Non Current - - - - - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities - - - 6.03 Million 3.18 Million 5.66 Million
Other Liabilities - - - - - -
Total Equity 131.97 Million 46.5 Million 72.61 Million 174.66 Million 166.27 Million 173.09 Million
Stock Holders Equity 131.97 Million 46.5 Million 72.61 Million 174.66 Million 166.27 Million 173.09 Million
Common Stock 15.5 Thousand 6371.00 5302.00 5222.00 4650.00 4527.00
Retained Earnings -324.67 Million -244.02 Million -204.34 Million -90.91 Million -64.18 Million -52.77 Million
Accumulated other comprehensive income -170.84 Thousand -29.88 Thousand -30.43 Thousand -10.83 Thousand -41.41 Thousand 101.81 Thousand
Common Stock Equity 131.97 Million 46.5 Million 72.61 Million 174.66 Million 166.27 Million 173.09 Million
Capital Lease Obligation 1.33 Million 969 Thousand 1.23 Million 1.53 Million 1.8 Million -
Total Investments - - - - - -
Total Debt 2.45 Million 5.59 Million 7.01 Million 7.31 Million 7.58 Million -
Net Debt 2.23 Million 3.71 Million -2.15 Million -13.35 Million -1.11 Million -12.28 Million

Balance Sheet Charts